Our hearts and minds are with all impacted by COVID-19, and we’d like to ensure those in the research community are aware of the high quality immunological data available for immediate use in ImmPort. ImmPort is a robust data repository sponsored by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Disease (NIAID). Data within ImmPort has been generated largely through clinical trials and research studies funded by the NIH and other public-private partnerships, and all data is freely available for re-use.
Examples of data types include:
- Immune profiles of over 10,000 healthy individuals (https://10kimmunomes.ucsf.edu/app/10kimmunomes; PMID: 30304689)
- Immunological data from studies related to malaria, influenza, and other infectious disease
- General vaccine response data
- Large data-sets from technologies such ELISA, RNA sequencing, flow cytometry, CyToF
ImmPort is a recommended data repository by PLOS One, Nature’s Scientific Data, and holds the Core Trust Seal of Approval for Core Trustworthy Data Repositories.
To browse data currently available in ImmPort, visit the ImmPort Shared Data page and use the search field or data visualizations to find studies of interest. For first-time users downloading data, you will need to register in order to create a login and password. As always, registration is simple and free.
In addition to providing data for re-use, ImmPort is listed by NIH as an open domain-specific data repository for upload of COVID-19 research data. ImmPort team members are available to help with data uploads. Please contact immport_COVID19@immport.org for assistance with COVID-19 related data sharing. We look forward to connecting with you.